Dr Christopher Rudge is a lecturer in private law at Sydney Law School and a member of Sydney Health Law. Christopher has degrees in arts and law. Christopher has a broad network of research collaborators in the sciences and social sciences across the world. His research analyses legal issues relevant to the regulation of innovative medical technologies, including genome editing (somatic and germline cells; CRISPR, TALENs and ZFN-based systems), stem cell-based interventions (including extracellular vesicles) and other innovative medical treatments in Australia.
Christopher was previously (2021) postdoctoral research fellow at the University of Tasmania's Centre for Law and Genetics under supervision of Distinguished Professor Dianne Nicol, Chair of the NHMRC Embryo Licensing Committee. Together with other researchers, they held the first citizens' jury on genome editing in the world. This was a project devoted to developing legal policy about genome editing in Australia. See https://www.australiancitizensjury.org/
Before then (2019), Christopher was postdoctoral research fellow at the University of Melbourne. There he worked under supervision of Professor Megan Munsie, Convenor of Stem Cells Australia, on a project investigating the regulation and governance of autologous stem cell therapies in Australia and globally.
In 2018, Christopher conducted a major review of the scope of disciplinary powers exercisable by the NSW medical regulator under the relevant health practitioner law. I have also published original research on the history and politics of novel psychiatric devices, including the e-meter and telepsychiatric devices. I have also published work on the legal frameworks regulating stem cell interventions in Australia and internationally.